Genomic Health To Pay $32.5M In Medicare Billing FCA Deal

By Rachel Riley · October 2, 2023, 7:50 PM EDT

A clinical diagnostic test supplier will pay $32.5 million to resolve allegations that it violated the False Claims Act by skirting Medicare rules to overbill the federal government for genomic-based lab...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America v. Genomic Health, Inc.

Case Number

1:16-cv-04038

Court

New York Eastern

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

July 21, 2016

Case Title

United States of America et al v. Genomic Health Inc et al

Case Number

1:17-cv-04460

Court

New York Eastern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

July 28, 2017